Ask AI
Public Law113th CongressSports and Recreation
S. 2338Became Law

United States Anti-Doping Agency Reauthorization Act

This bill became law

Filed
Comm.
Floor
Both
Law

What it doesSummary public law (Dec 18, 2014)

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.

What just happenedDec 18, 2014

Became Public Law No: 113-280.

Who’s behind it

Sen. Rockefeller, John D., IV [D-WV](D-WV)Sponsor
2 cosponsors2 R
Read on Congress.gov
2cosponsors1committees21actions1related bills4subjects
  1. Dec 18, 2014President

    Became Public Law No: 113-280.

  2. Dec 18, 2014BecameLaw36000

    Became Public Law No: 113-280.

  3. Dec 18, 2014President

    Signed by President.

  4. Dec 18, 2014BecameLaw36000

    Signed by President.

  5. Dec 17, 2014Floor

    Presented to President.

  6. Dec 17, 2014President28000

    Presented to President.

  7. Dec 12, 2014FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  8. Dec 12, 2014FloorH37100

    On passage Passed without objection. (text: CR H10314)

  9. Dec 12, 2014Floor8000

    Passed/agreed to in House: On passage Passed without objection.(text: CR H10314)

  10. Dec 12, 2014FloorH30200

    Mr. Flores asked unanimous consent to take from the Speaker's table and consider.

  11. Dec 12, 2014FloorH30000

    Considered by unanimous consent. (consideration: CR H10314)

  12. Dec 12, 2014FloorH14000

    Received in the House.

  13. Dec 12, 2014Floor

    Message on Senate action sent to the House.

  14. Dec 11, 2014Floor

    Passed Senate without amendment by Unanimous Consent. (consideration: CR S6697; text as passed Senate: CR S6697)

  15. Dec 11, 2014Floor17000

    Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S6697; text as passed Senate: CR S6697)

  16. Dec 1, 2014Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 608.

  17. Dec 1, 2014Committee

    Committee on Commerce, Science, and Transportation. Reported by Senator Rockefeller without amendment. With written report No. 113-281.

    Commerce, Science, and Transportation Committee
  18. Dec 1, 2014Committee14000

    Committee on Commerce, Science, and Transportation. Reported by Senator Rockefeller without amendment. With written report No. 113-281.

    Commerce, Science, and Transportation Committee
  19. Sep 17, 2014Committee

    Committee on Commerce, Science, and Transportation. Ordered to be reported without amendment favorably.

    Commerce, Science, and Transportation Committee
  20. May 14, 2014IntroReferral

    Read twice and referred to the Committee on Commerce, Science, and Transportation.

    Commerce, Science, and Transportation Committee
  21. May 14, 2014IntroReferral10000

    Introduced in Senate

Public LawDec 18, 201449

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.

Passed House without amendmentDec 12, 201481

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.

Passed Senate without amendmentDec 11, 201482

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.

Reported to Senate without amendmentDec 1, 201480

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.

Introduced in SenateMay 14, 2014

United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.